R61 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM R61 became effective on October 1, 2024. This is the American ICD-10-CM version of R61 - other international versions of …

2024年9月24日 · As part of a bi-phasic approach to funding exploratory and/or developmental research, the R61 provides support for the first phase of the award. This activity code is used in lieu of the R21 activity code when larger budgets and/or project periods are required to establish feasibility for the project.

R61 is a billable diagnosis code used to specify a medical diagnosis of generalized hyperhidrosis. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2024 through September 30, 2025.

2024年11月7日 · This NOFO utilizes NIH’s R61/R33 Exploratory/Developmental Phased Award activity code. The R61 phase provides up to 2 years of support for initial developmental activities. The R33 phase provides up to 3 years of support for expanded activities.

Learn more about the program by reading the funding opportunities or browsing the funded projects from over the years. Read the RFAs for novel technology development projects. IMAT uses the R61 grant mechanism to support early-stage, proof-of-concept studies.

2024年4月8日 · Conducting early-stage safety/tolerability/dose/efficacy trials with drugs, biologics, devices, behavioral interventions, and/or physical therapy for treatment of arthritis, musculoskeletal or skin disease.

Get crucial instructions for accurate ICD-10-CM R61 coding with all applicable Excludes 1 and Excludes 2 notes from the section level conveniently shown with each code.

2022年9月1日 · The R61 phase will be up to one year, and will support developmental, exploratory research, Institutional Review Board approval for human subjects protection, further development of study partnerships, and the collection of baseline data.

2023年7月24日 · The R61 is used in place of the R21 when larger budgets and/or project periods are needed in order to establish the feasibility of the project. The R33 mechanism provides a second phase of funding for exploratory/developmental grants.

R61 is a valid billable ICD-10 diagnosis code for Generalized hyperhidrosis. It is found in the 2025 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2024 - Sep 30, 2025 .